Durvalumab vs Nitroglycerin

## Durvalumab vs Nitroglycerin: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Nitroglycerin**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Nitroglycerin**: Nitric oxide donor causing venous and arterial vasodilation.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Nitroglycerin — 1-4 minutes.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Nitroglycerin — C3H5N3O9.

**Molecular Weight**: Durvalumab — N/A; Nitroglycerin — 227.0870 g/mol.

**Type**: Durvalumab — Antibody; Nitroglycerin — Small molecule.